NCT04645199
National Longitudinal Cohort of Hematological Diseases No drug interventions Not Available Not Available recruiting NCT05681845
A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge No drug interventions treatment 1 completed NCT06649630
A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men No drug interventions treatment 1 recruiting NCT05053139
A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors No drug interventions treatment 3 recruiting NCT05685238
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4) No drug interventions treatment 3 recruiting NCT03055611
A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B Not Available Not Available completed NCT06285071
Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors Not Available Not Available enrolling_by_invitation NCT06574984
Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients Not Available Not Available not_yet_recruiting NCT02035384
Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A Not Available Not Available completed NCT01562587
Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State treatment 1 completed NCT04682145
Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol Not Available Not Available enrolling_by_invitation NCT03196297
A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors treatment 2 completed NCT01493778
Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A treatment 3 completed NCT00837356
Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects treatment 1 completed NCT01988532
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia No drug interventions Not Available Not Available completed NCT01272206
Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects No drug interventions treatment 1 completed NCT01555749
Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects No drug interventions treatment 1 completed NCT02207218
To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan Not Available Not Available completed NCT02300519
Thrombin Generation Numerical Models Validation in Haemophilic Case No drug interventions Not Available Not Available completed NCT05082116
Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10) treatment 3 completed NCT04165135
An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment No drug interventions Not Available Not Available completed NCT03276130
Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B No drug interventions Not Available Not Available completed NCT00984126
Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 treatment 3 completed NCT02781766
TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia No drug interventions other Not Available unknown_status NCT03660774
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia No drug interventions Not Available Not Available completed NCT02250482
An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery. treatment 3 completed NCT00951873
A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers treatment 1 completed NCT04574076
A Study Following Males With Haemophilia A on Prophylaxis With Esperoct® Not Available Not Available enrolling_by_invitation NCT02207894
A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI No drug interventions Not Available Not Available recruiting NCT00922792
Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B treatment 1 completed NCT01949792
A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors treatment 1 completed NCT01238367
A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543 treatment 1 completed NCT01503567
Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries No drug interventions Not Available Not Available completed NCT01138501
Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A treatment 3 completed NCT02246868
An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients. treatment 3 completed NCT01228669
Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B No drug interventions treatment 1 completed NCT03741881
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) No drug interventions Not Available Not Available completed NCT02137850
Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A treatment 3 completed NCT02490787
Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects treatment 1 completed NCT02941354
Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A treatment 1 completed NCT03528551
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A treatment 3 completed NCT01234545
Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors Not Available Not Available completed NCT02920398
A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A treatment 1 completed NCT00245297
Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes. prevention 2 completed NCT01489111
Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. treatment 3 completed NCT00486278
Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds treatment 2 completed NCT03695978
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients No drug interventions Not Available Not Available recruiting NCT02994407
Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A treatment 1 completed NCT02938585
Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A treatment 3 completed NCT01731600
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A treatment 3 completed NCT01811875
Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A treatment 4 terminated NCT03449342
Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period treatment 4 completed NCT01631942
A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects No drug interventions treatment 1 terminated NCT02049099
A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care No drug interventions Not Available Not Available completed NCT01220141
Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B Not Available Not Available completed NCT03588741
Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial treatment 3 terminated NCT04675541
Register of Patients With haEmophilia A tReated With Afstyla® Not Available Not Available active_not_recruiting NCT01205724
Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A treatment 1 completed NCT06352216
Prevalence of Synovitis in Patients With Haemophilia A No drug interventions Not Available Not Available recruiting NCT00853086
Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database Not Available Not Available completed NCT00840086
Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects treatment 3 completed NCT01692925
Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A treatment 1 completed NCT01436825
Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients Not Available Not Available completed NCT03179748
Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A Patients Not Available Not Available completed NCT01311648
BAY81-8973 Pediatric Safety and Efficacy Trial treatment 3 completed NCT04334057
Post-Marketing Surveillance (Use-results Surveillance) With Esperoct® Not Available Not Available enrolling_by_invitation NCT01562457
Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State treatment 1 completed NCT01365520
A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A treatment 1 completed NCT01322620
Survey Evaluating the Psychosocial Effects of Living With Haemophilia No drug interventions Not Available Not Available completed NCT02246894
A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A. Not Available 3 completed NCT02241694
To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives No drug interventions Not Available Not Available completed NCT01288391
Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients No drug interventions treatment 1 completed NCT01480180
Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A treatment 3 completed NCT04584892
Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities Not Available Not Available completed NCT00638001
Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy No drug interventions treatment 4 completed NCT05621746
An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct Not Available Not Available recruiting NCT02084810
Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects treatment 1 withdrawn NCT01959555
Project to Update the Study of Congenital Haemophilia in Spain No drug interventions Not Available Not Available completed NCT05878938
A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5) No drug interventions treatment 3 active_not_recruiting NCT05932914
Liver Biopsy Following Gene Therapy For Hemophilia No drug interventions Not Available Not Available not_yet_recruiting NCT05987449
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A No drug interventions treatment 1 / 2 recruiting NCT06568302
The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial treatment 3 recruiting NCT06649175
Effect of Kinetic Chain Exercises on Muscle Strength, Joint Position Sense and Quality of Life in Children with Haemophilia. No drug interventions treatment Not Available not_yet_recruiting NCT06530030
Goal Attainment and Physical Activity in People With Hemophilia A Not Available Not Available not_yet_recruiting NCT02941783
Drug Use Investigation of Kovaltry in Hemophilia A Patients Not Available Not Available active_not_recruiting NCT03587116
A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) No drug interventions other 3 active_not_recruiting NCT03938792
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B treatment 3 active_not_recruiting NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors treatment 3 recruiting NCT05568719
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively No drug interventions other 3 recruiting NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B treatment 3 recruiting NCT06634836
Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B No drug interventions Not Available Not Available not_yet_recruiting NCT02976753
Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products Not Available Not Available completed NCT04293523
A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health Not Available Not Available active_not_recruiting NCT05036278
Prophylaxis Regimen for Hemophilia A Patients treatment 4 active_not_recruiting NCT05147662
A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood treatment 3 active_not_recruiting NCT06222697
A Study to Learn More About the Safety of Damoctocog-alfa-pegol When Used in Routine Medical Care in Korean Participants With Hemophilia A Not Available Not Available recruiting NCT04563520
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis treatment 3 recruiting NCT04731701
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST) No drug interventions Not Available Not Available completed NCT05248594
Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A Not Available Not Available recruiting NCT05605678
Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5) No drug interventions Not Available Not Available recruiting NCT05707351
A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A treatment 3 completed NCT05789524
The Efficacy and Safety of SerpinPC in Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B treatment 2 recruiting NCT06025552
Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects No drug interventions treatment 1 completed NCT06349473
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B) No drug interventions treatment 1 recruiting NCT04677803
BT200 in Hereditary Bleeding Disorders treatment 2 completed NCT04805021
Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells No drug interventions Not Available Not Available recruiting NCT02622321
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors treatment 3 completed NCT02492984
PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A treatment 4 completed NCT01064284
Survey of Inhibitors in Plasma-Product Exposed Toddlers basic_science 4 completed NCT03327779
World Bleeding Disorders Registry No drug interventions Not Available Not Available recruiting NCT01159587
Prophylaxis Versus On-demand Therapy Through Economic Report Not Available Not Available completed NCT02479087
Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients treatment 4 unknown_status NCT02911233
Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C Activation Capacity No drug interventions Not Available Not Available completed NCT03003533
A Gene Transfer Study for Hemophilia A No drug interventions treatment 1 / 2 completed NCT00281333
The Influence of "Karate" on Bleeding in Hemophilic Patients. No drug interventions prevention Not Available terminated NCT04560933
A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A No drug interventions Not Available Not Available completed NCT04370054
Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults treatment 3 active_not_recruiting NCT00168051
Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A treatment 4 withdrawn NCT03747653
A Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection Not Available Not Available unknown_status NCT02807753
The Hemophilia Ultrasound Project No drug interventions Not Available Not Available terminated NCT00157053
Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901 treatment 2 / 3 completed NCT05980377
Patterns of Hemophilia Care in Assiut Children Patients No drug interventions Not Available Not Available not_yet_recruiting NCT01460147
Osteoporosis and MRI Study in Hemophilia No drug interventions diagnostic Not Available terminated NCT02727647
Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients treatment 4 completed NCT02921945
Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A treatment 3 unknown_status NCT03417245
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors treatment 3 completed NCT02895945
BAX 802 in CHA With Inhibitors treatment 3 terminated NCT00936845
Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study No drug interventions Not Available Not Available completed NCT04941898
A Study of TAK-660 in Surgical Procedures for People With Hemophilia A. Not Available Not Available completed NCT00157105
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery treatment 2 / 3 completed NCT06212505
EVALUATION OF THE OVERALL HAEMOSTATIC CAPACITY OF MIM8 WITH GLOBAL HAEMOSTASIS ASSAYS AND FIBRIN CLOT ULTRASTRUCTURE No drug interventions Not Available Not Available recruiting NCT02035605
A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients treatment 1 completed NCT00207597
Joint Outcome Study No drug interventions Not Available Not Available completed NCT03185897
Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia No drug interventions Not Available Not Available completed NCT00922597
Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery Not Available Not Available completed NCT05449197
Evaluation of the Training Program for Community Pharmacists for Dispensing Emicizumab (HEMLIBRA®) in France No drug interventions Not Available Not Available completed NCT02225483
Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function No drug interventions Not Available Not Available completed NCT05523128
The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients. No drug interventions treatment Not Available not_yet_recruiting NCT01790828
Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A Not Available Not Available completed NCT01580293
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A treatment 2 / 3 completed NCT00947193
Study of Ataluren (PTC124) in Hemophilia A and B treatment 2 terminated NCT00007371
Hepatitis C in Clinically Discordant Hemophilic Siblings No drug interventions Not Available Not Available completed NCT00279578
Clot Formation and Clot Stability in Patients With Severe Haemophilia A treatment Not Available completed NCT00178607
Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia No drug interventions Not Available Not Available completed NCT00038909
Study Evaluating ReFacto in Hemophilia A No drug interventions treatment Not Available completed NCT04061109
Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. No drug interventions prevention 3 unknown_status NCT00357656
Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery treatment 4 completed NCT04590456
Pulsed Electromagentic Field in Haemophilia No drug interventions treatment Not Available unknown_status NCT02392156
Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes Not Available Not Available terminated NCT02750085
Evaluation of a Simple Pharmacokinetic Tool (myPKFiT™) to Guide Personalized Factor VIII Dosing in Patients With Hemophilia No drug interventions Not Available Not Available unknown_status NCT02847637
A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors treatment 3 completed NCT00916032
Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A treatment 4 completed NCT00864552
International PMS Study - KOGENATE Bayer Not Available Not Available completed NCT04953000
A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A No drug interventions Not Available Not Available completed NCT00212459
The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs No drug interventions Not Available Not Available completed NCT00243659
Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery treatment 3 completed NCT04644575
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A treatment 3 active_not_recruiting NCT01736475
Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study) prevention 2 / 3 completed NCT03603275
Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry Not Available Not Available terminated NCT02319070
2-cohort Study of Adult Patients With Severe Hemophilia A in Greece No drug interventions Not Available Not Available completed NCT00306670
Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A treatment 2 / 3 terminated NCT05439642
Validation and Reliability of the CHO-KLAT in Turkish No drug interventions diagnostic Not Available unknown_status NCT03103542
Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies treatment 4 completed NCT02476942
A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment No drug interventions Not Available Not Available completed NCT04845399
Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A treatment 3 completed NCT03191799
A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors treatment 3 completed NCT00666406
Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A treatment 4 completed NCT00331006
Rituximab to Treat Severe Hemophilia A treatment 2 completed NCT05879549
Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises Patient With Hemophilia No drug interventions treatment Not Available recruiting NCT04131036
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A No drug interventions Not Available Not Available recruiting NCT05187936
Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy No drug interventions Not Available Not Available unknown_status NCT05981313
Viscoelastic Properties of Lower Extremity Muscles in Patients With Hemophilia No drug interventions Not Available Not Available not_yet_recruiting NCT02740413
Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study No drug interventions Not Available Not Available completed NCT00005518
Epidemiology and Immunology of Hemophilia A Inhibitors No drug interventions Not Available Not Available completed NCT03815318
Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A prevention 3 completed NCT01510418
Socialization of Adult Men With Congenital Hemophilia A or B No drug interventions Not Available Not Available completed NCT01599819
BAX 855 Dose-Escalation Safety Study treatment 1 completed NCT00969319
Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America Not Available Not Available completed NCT01959919
Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO No drug interventions Not Available Not Available completed NCT04023019
Treatment of Hemophilia A Patients With FVIII Inhibitors Not Available Not Available recruiting NCT04728841
Gene Therapy for Chinese Hemophilia A No drug interventions treatment Not Available recruiting NCT04728217
Health Related Quality of Life of Youth and Young Adults With Haemophilia A prevention 4 completed NCT02930317
Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A treatment 3 unknown_status NCT02199717
An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia No drug interventions Not Available Not Available completed NCT06158334
Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®) Not Available Not Available recruiting NCT00214734
ADVATE Post Authorization Safety Surveillance Not Available Not Available completed NCT02634424
PK Driven Prophylaxis for Hemophilia A No drug interventions supportive_care Not Available terminated NCT03205163
A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A) other 1 / 2 completed NCT00243386
Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A treatment 4 completed NCT06297486
Study of a Gene Therapy Treatment for Hemophilia A No drug interventions treatment 3 recruiting NCT04396639
Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients treatment 4 completed NCT00543439
Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII treatment 3 completed NCT02726139
Improved Factor VIII Inhibitor Evaluation No drug interventions Not Available Not Available withdrawn NCT03204539
INdividualized ITI Based on Fviii(ATE) Protection by VWF treatment 4 terminated NCT01454739
Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A treatment 3 completed NCT04690322
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies treatment 4 recruiting NCT02971930
Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A Not Available Not Available completed NCT00868530
Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects treatment 3 completed NCT03001830
Gene Therapy for Haemophilia A. No drug interventions treatment 1 / 2 recruiting NCT04676048
ASC618 Gene Therapy in Hemophilia A Patients treatment 1 / 2 recruiting NCT00717626
Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A treatment 2 completed NCT00874926
EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS Not Available Not Available completed NCT00765726
Study Evaluating The Safety Of Xyntha In Usual Care Settings treatment 4 terminated NCT02263066
Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis No drug interventions Not Available Not Available completed NCT02962765
Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ No drug interventions Not Available Not Available completed NCT06273865
Version Testing of EnzySystem Version A for Hemophilia A No drug interventions Not Available Not Available suspended NCT04876365
A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate No drug interventions Not Available Not Available completed NCT03379974
Exercise Versus DDAVP in Patients With Mild Hemophilia A treatment 4 completed NCT03947320
Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A. prevention 3 unknown_status NCT03432520
Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A No drug interventions Not Available Not Available active_not_recruiting NCT01184820
Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration basic_science 1 completed NCT00189982
Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 No drug interventions treatment 2 / 3 completed NCT03507582
Virtual Reality for Hemophilia No drug interventions other Not Available completed NCT04985682
A Study of ADVATE in People With Hemophilia A in India treatment 4 completed NCT01541527
Non Neutralizing Antibodies: Prevalence and Characterization No drug interventions Not Available Not Available withdrawn NCT03834727
Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders No drug interventions Not Available Not Available completed NCT01486927
An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A treatment 2 / 3 completed NCT02078427
ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD) Not Available Not Available completed NCT01652027
Hemophilia Inhibitor Previously Untreated Patient Study No drug interventions Not Available Not Available completed NCT00092976
Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery treatment 4 completed NCT02585960
BAX 855 PK-guided Dosing prevention 3 completed NCT02582060
Individualizing Hemophilia Prophylaxis Using Thromboelastography No drug interventions other Not Available completed NCT05643560
An Observational Study Called JOIHA to Learn More About How Well the Treatment With Jivi Works to Prevent Problems With Joints in Adults With Hemophilia A Not Available Not Available recruiting NCT02716194
BAX 826 Dose-Escalation Safety Study treatment 1 completed NCT01568580
Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A No drug interventions treatment 3 completed NCT00623480
Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment treatment 3 completed NCT03380780
A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese Volunteers treatment 1 completed NCT03818529
ATHN 8: Previously Untreated Patients (PUPs) Matter Study No drug interventions Not Available Not Available completed NCT00994929
Efficacy and Safety of IL-11 in DDAVP Unresponsive treatment 2 completed NCT02461992
Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A basic_science 1 completed NCT04015492
Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII) treatment 1 completed NCT06579144
Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A other 1 not_yet_recruiting NCT00157040
Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A treatment 2 / 3 completed NCT05450640
Satisfaction Regarding the Dispensing of Emicizumab (HEMLIBRA®) for Patients With Haemophilia A in France No drug interventions Not Available Not Available completed NCT01029340
Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A treatment 3 completed NCT05606640
Gaining Insight Into the Complexity of Pain in Patients With Haemophilia No drug interventions Not Available Not Available completed NCT03876301
Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants No drug interventions Not Available Not Available completed NCT03533504
Web Accessible Population Pharmacokinetics Service - Hemophilia: Sources of Variability No drug interventions Not Available Not Available enrolling_by_invitation NCT01034904
Health Related Quality of Life of Youth and Young Adults With Hemophilia A No drug interventions Not Available Not Available completed NCT06357572
Real-life Clinical FEIBA Samples Measured Using the Version A of the HemA EnzySystem No drug interventions Not Available Not Available completed NCT02061072
Web-based Application for the Population Pharmacokinetic Service - Phase 1 No drug interventions Not Available Not Available completed NCT02528968
National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A No drug interventions other Not Available completed NCT02571569
A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors basic_science 1 completed NCT04472169
UPLC-MS/MS Monitoring of Emicizumab Therapy No drug interventions Not Available Not Available recruiting NCT02622646
Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients No drug interventions Not Available Not Available unknown_status NCT01619046
Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A treatment 3 unknown_status NCT00936312
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study No drug interventions Not Available Not Available completed NCT06565481
Measurement Properties in People With Hemophilia No drug interventions other Not Available not_yet_recruiting NCT00797381
Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia No drug interventions Not Available Not Available unknown_status NCT06147414
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders No drug interventions Not Available Not Available not_yet_recruiting NCT00932555
EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan Not Available Not Available completed NCT01921855
Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors treatment 1 completed NCT04845555
Association Between Individual Clotting Factor Level Monitoring and the Risk of Bleeding Whilst Physical Active Conditions No drug interventions Not Available Not Available unknown_status NCT00759655
Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age treatment 3 terminated NCT06297655
A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A treatment 3 not_yet_recruiting NCT02172950
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A No drug interventions treatment 3 completed NCT02234323
An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A treatment 3 completed NCT02506023
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers diagnostic 1 completed NCT02634723
Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A Not Available Not Available completed NCT03655223
Early Check: Expanded Screening in Newborns No drug interventions Not Available Not Available enrolling_by_invitation NCT02483208
Single Dose Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and Advate basic_science 1 completed NCT06238908
Safety and Efficacy Study of NGGT003 in Hemophilia A Patients No drug interventions treatment 0 not_yet_recruiting NCT06111638
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs No drug interventions treatment 1 / 2 recruiting NCT02912143
German Pediatric Hemophilia Research Database No drug interventions Not Available Not Available recruiting NCT01579903
Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC) Not Available 1 completed NCT03344003
Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq Not Available Not Available terminated NCT05856903
Impact of Emicizumab on Activated Clotting Time Using the i-STAT Alinity Analyzer No drug interventions Not Available Not Available recruiting NCT00884390
Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings treatment 4 terminated NCT05251090
A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection treatment 1 completed NCT00586521
BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) treatment 4 completed NCT00851721
Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor treatment 3 completed NCT00839202
Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay No drug interventions basic_science Not Available completed NCT03417102
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors treatment 3 completed NCT02170402
China ADVATE PTP Study prevention 4 completed NCT02027779
Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A No drug interventions treatment 3 unknown_status NCT04456387
An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A. treatment 3 completed NCT02061033
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease No drug interventions Not Available Not Available unknown_status NCT03615053
Personalized Medicine for Canadians With Hemophilia No drug interventions other Not Available recruiting NCT03286153
Comparison of Ideal vs. Actual Weight Base Factor Dosing No drug interventions health_services_research Not Available unknown_status NCT02718677
Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis Not Available Not Available withdrawn NCT00245245
Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII treatment 2 completed NCT04073498
The Safety and Tolerability of SerpinPC in Healthy Men and in Men With Severe Blood Disorders (Haemophilia A and B) treatment 1 / 2 active_not_recruiting NCT03364998
BAY94-9027 PK Study Comparing to Another Long Acting Product basic_science 1 completed NCT00824798
Gait Evaluation in Haemophiliac Patients No drug interventions Not Available Not Available completed NCT04323098
Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A treatment 3 active_not_recruiting NCT01757405
Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen treatment 3 completed NCT01913405
Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures treatment 3 completed NCT00000705
Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia treatment 1 completed NCT01626105
Personalized Prediction of Tolerance and Immunogenicity in Hemophilia No drug interventions Not Available Not Available unknown_status NCT00005305
Hepatitis Delta Infections in Hemophiliacs No drug interventions Not Available Not Available completed NCT01445197
Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development No drug interventions treatment 3 terminated NCT02674997
GAS-Hem Feasibility Study Not Available Not Available completed NCT04133883
Impact on French Physician's Haemophilia Treatment Management Decision Based on Systematic Joint Examination No drug interventions health_services_research Not Available completed NCT04541628
Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A treatment 1 / 2 terminated NCT01434511
Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A No drug interventions treatment 3 terminated NCT00284193
Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII treatment 4 completed NCT01945593
BAX 855 Continuation prevention 3 completed NCT02418793
A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B treatment 1 completed NCT01439971
Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia basic_science 1 completed NCT04784988
Intensive Replacement Treatment in Haemophilia Patients With Synovitis No drug interventions treatment 4 completed NCT01229007
Study of Biostate® in Children With Hemophilia A No drug interventions treatment 3 completed NCT01318707
Biomarkers Serum Collection Methodology Pilot Study No drug interventions Not Available Not Available completed NCT06224907
Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A treatment 3 active_not_recruiting NCT00005309
Prospective Study of HIV Infection in Hemophiliacs No drug interventions Not Available Not Available completed NCT02938156
UK - EHL Outcomes Registry No drug interventions Not Available Not Available unknown_status NCT00151385
Study Evaluating Inhibitor Specificity in Hemophilia A No drug interventions diagnostic 4 withdrawn NCT01053715
Quality of Life Study of Helixate NexGen No drug interventions Not Available Not Available completed NCT00629837
Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980 treatment 1 completed NCT01477437
Internet-based Educational Program to Promote Self-Management for Teens With Hemophilia No drug interventions supportive_care Not Available completed NCT03405337
Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement Therapies No drug interventions Not Available Not Available completed NCT03154437
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors Not Available Not Available approved_for_marketing NCT04072237
Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia No drug interventions diagnostic 1 completed NCT03361137
Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures treatment 4 terminated NCT00895037
Study Evaluating Pharmacovigilance Of Refacto AF Not Available Not Available completed NCT03217032
Lentiviral FVIII Gene Therapy No drug interventions treatment 1 unknown_status NCT04030052
Emicizumab PUPs and Nuwiq ITI Study prevention 3 withdrawn NCT01376700
Early Prophylaxis Immunologic Challenge (EPIC) Study prevention 3 terminated NCT05022459
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis Not Available Not Available recruiting NCT00914459
Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients treatment 4 completed NCT04541875
Medication Adherence and Non-adherence in Adults With Rare Disease No drug interventions Not Available Not Available withdrawn NCT00950170
Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting No drug interventions other 4 completed NCT00195442
Study Evaluating Refacto For Pharmacovigilance Not Available Not Available completed NCT03588299
Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle". treatment 1 / 2 active_not_recruiting NCT01458106
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A treatment 3 completed NCT01090206
Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia No drug interventions screening Not Available completed NCT02190149
Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS Not Available Not Available completed NCT00289536
Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A treatment 4 completed NCT04060836
Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. prevention 1 unknown_status NCT04303936
PHYSICAL ACTIVITY AND FVIII CLEARANCE: RELEVANCE FOR PERSONALIZED THERAPY IN SEVERE HAEMOPHILIA A (PHYSEMO) No drug interventions other Not Available unknown_status NCT04565236
A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A treatment 4 completed NCT03370913
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301) treatment 3 active_not_recruiting NCT05281718
Factor IX as Adjunctive Therapy to Emicizumab (EMIX) basic_science 0 recruiting NCT02634918
Ultrasonography in Hemophilic Joint Disease and Serum Markers No drug interventions Not Available Not Available completed NCT01775618
Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A treatment 3 completed NCT05754619
Emotions in the Communication and Relationship Styles of Parents With Hemophilic Children. No drug interventions Not Available Not Available recruiting NCT00162019
Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients diagnostic 3 completed NCT02093741
ADVATE 2 mL Post-Authorization Safety Surveillance (PASS) Not Available Not Available completed NCT00879541
Study of a pd vWF/FVIII, Biostate®, in Subjects With Haemophilia A treatment 2 completed NCT03248141
Understanding Hemophilia A and B Drug Dosage Administration Patterns No drug interventions Not Available Not Available terminated NCT01571934
Inhibitor Development in Patients With Hemophilia A Undergoing Surgery No drug interventions Not Available Not Available completed NCT05804734
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia Not Available Not Available completed NCT04158934
A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A Not Available Not Available active_not_recruiting NCT05279924
Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast treatment Not Available completed NCT04621916
Preventing Inhibitor Recurrence Indefinitely prevention 4 active_not_recruiting NCT00989196
Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A treatment 2 completed NCT01233258
A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A treatment 3 completed NCT04085458
Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation) treatment 4 completed NCT05395858
A Study to Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice ("Real-World"), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment Centers No drug interventions Not Available Not Available terminated NCT00038935
Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A treatment 3 completed NCT06185335
A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A No drug interventions treatment 1 / 2 recruiting NCT05911763
A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A Not Available Not Available recruiting NCT03818763
Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A treatment 1 recruiting NCT05636163
Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratio in Predicting the Incidence of Nausea and Vomiting No drug interventions Not Available Not Available not_yet_recruiting NCT00002386
Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia treatment 4 completed NCT04091386
Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study) Not Available Not Available active_not_recruiting NCT05768386
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401) No drug interventions Not Available Not Available enrolling_by_invitation NCT04461639
Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding Not Available Not Available active_not_recruiting NCT01653639
Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222 treatment 1 completed NCT03824522
Post Marketing Surveillance Study for ADYNOVATE in South Korea Not Available Not Available completed NCT00952822
Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for Injection other 1 completed NCT04583930
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis No drug interventions Not Available Not Available unknown_status NCT01589848
Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador No drug interventions Not Available Not Available completed NCT04158648
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors treatment 3 active_not_recruiting NCT00157157
Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients No drug interventions treatment 3 completed NCT06104826
Health-Related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on Emicizumab Not Available Not Available not_yet_recruiting NCT05856266
An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa No drug interventions other 4 terminated NCT01810666
Prophylaxis Versus on Demand Treatment for Children With Hemophilia A treatment 4 completed NCT05752565
Physical Activity and FVIII Elimination: Relevance to Personalized Therapy in Severe Hemophilia A No drug interventions other Not Available completed NCT03006965
Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT® Not Available Not Available completed NCT02093065
Platelet Function in Patients With Hemophilia A No drug interventions Not Available Not Available completed NCT02280265
Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A treatment Not Available unknown_status NCT03392974
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg treatment 3 completed NCT05687474
Baby Detect : Genomic Newborn Screening No drug interventions Not Available Not Available recruiting NCT05454774
A Study of FVIII Gene Therapy for Hemophilia A No drug interventions treatment 0 not_yet_recruiting NCT04131920
Handheld Ultrasound (HHUS) for Home Use in Hemophilia No drug interventions Not Available Not Available completed NCT06014320
Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease No drug interventions Not Available Not Available not_yet_recruiting NCT00000582
Cooperative Study of Factor VIII Inhibitors treatment 3 completed NCT02851082
Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study. No drug interventions treatment Not Available completed NCT04759131
Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A treatment 3 completed NCT03313531
Evaluation of a Standardized Protocol for Thrombin Generation Assay No drug interventions Not Available Not Available completed NCT00621673
Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A supportive_care 4 terminated NCT02554773
An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B treatment 1 / 2 completed NCT06145373
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab treatment 1 recruiting NCT00623727
BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A treatment 2 terminated NCT00002276
The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia treatment Not Available completed NCT05487976
Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor treatment 3 unknown_status NCT03020160
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A prevention 3 completed NCT02210091
BAX 855 Pediatric Study treatment 3 completed NCT02615691
A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A treatment 3 active_not_recruiting NCT02396862
Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment Not Available Not Available completed NCT05936580
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery treatment 4 recruiting NCT03915080
Optimizing the Use of Prophylaxis in Patients With Severe Haemophilia A other 4 completed NCT02402829
A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture No drug interventions Not Available Not Available terminated NCT02284789
Colorado Adult Joint Assessment Scale (CAJAS) Validation No drug interventions Not Available Not Available completed NCT05580692
A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV) No drug interventions other Not Available terminated NCT00037544
Study Evaluating ReFacto AF in Severe Hemophilia A treatment 3 completed NCT06369740
Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia A Monitoring No drug interventions Not Available Not Available not_yet_recruiting NCT05042440
Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A treatment 1 completed NCT03947567
Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients. prevention 4 recruiting NCT02795767
A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors treatment 3 completed NCT00927667
Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens No drug interventions diagnostic 4 completed NCT05265767
Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A treatment 1 completed NCT03932201
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A Not Available Not Available active_not_recruiting NCT03061201
A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A treatment 2 completed NCT01748201
Viscosupplementation in Patients With Hemophilic Arthropathy No drug interventions treatment 4 completed NCT00005304
Delta Hepatitis and Liver Disease in Hemophiliacs No drug interventions Not Available Not Available completed NCT03370172
A Study of BAX 888 in Male Adults With Severe Hemophilia A prevention 1 / 2 active_not_recruiting NCT03169972
ADYNOVATE Drug Use-Results Survey Not Available Not Available completed NCT01386268
Kogenate FS Regulatory Post-Marketing Surveillance Not Available Not Available completed NCT02581969
Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A." Not Available Not Available completed NCT00995046
Individually Tailored Prophylaxis in Patients With Severe Hemophilia A No drug interventions Not Available Not Available terminated NCT03520712
Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5 treatment 1 / 2 active_not_recruiting NCT02282410
Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A treatment Not Available unknown_status NCT02362581
Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A No drug interventions treatment Not Available completed NCT04418414
Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A No drug interventions treatment 1 not_yet_recruiting NCT00632814
Russian Kogenate Pediatric Study treatment 4 completed NCT03315455
Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants treatment 3 active_not_recruiting NCT01217255
Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World No drug interventions Not Available Not Available completed NCT00375323
Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation Not Available 3 completed NCT02888223
Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A treatment 1 unknown_status NCT00581438
Study Evaluating Approach to Treatment of Haemophilia A and B in Spain No drug interventions Not Available Not Available completed NCT00141843
Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A No drug interventions prevention 3 completed